cIMPACT-NOW update 4: diffuse gliomas characterized by MYB, MYBL1, or FGFR1 alterations or BRAFV600E mutation
- 8 March 2019
- journal article
- letter
- Published by Springer Science and Business Media LLC in Acta Neuropathologica
- Vol. 137 (4), 683-687
- https://doi.org/10.1007/s00401-019-01987-0
Abstract
No abstract availableThis publication has 28 references indexed in Scilit:
- BRAF Mutation and CDKN2A Deletion Define a Clinically Distinct Subgroup of Childhood Secondary High-Grade GliomaJournal of Clinical Oncology, 2015
- International Society of Neuropathology‐Haarlem Consensus Guidelines for Nervous System Tumor Classification and GradingBrain Pathology, 2014
- Posterior fossa and spinal gangliogliomas form two distinct clinicopathologic and molecular subgroupsActa Neuropathologica Communications, 2014
- Paediatric and adult glioblastoma: multiform (epi)genomic culprits emergeNature Reviews Cancer, 2014
- Genome sequencing of 161 Mycobacterium tuberculosis isolates from China identifies genes and intergenic regions associated with drug resistanceNature Genetics, 2013
- Genomic analysis of diffuse pediatric low-grade gliomas identifies recurrent oncogenic truncating rearrangements in the transcription factorMYBL1Proceedings of the National Academy of Sciences of the United States of America, 2013
- Whole-genome sequencing identifies genetic alterations in pediatric low-grade gliomasNature Genetics, 2013
- Long-term follow-up of the multicenter, multidisciplinary treatment study HIT-LGG-1996 for low-grade glioma in children and adolescents of the German Speaking Society of Pediatric Oncology and HematologyNeuro-Oncology, 2012
- A multivariate analysis of factors determining tumor progression in childhood low-grade glioma: a population-based cohort study (CCLG CNS9702)Neuro-Oncology, 2010
- Clinical and Molecular Characteristics of Malignant Transformation of Low-Grade Glioma in ChildrenJournal of Clinical Oncology, 2007